glp-1 drugs and alzheimer's Novo Nordisk's oral drug didn't work on as hoped, but don't call it a failure Alzheimer's disease: Semaglutide use linked

In the STEP 1 semaglutide trial (Wilding et al., NEJM , 2021) and the SURMOUNT-1 tirzepatide trial (Jastreboff et al., NEJM , 2022), nausea affected roughly 44% of semaglutide patients and about 24% of tirzepatide patients at the maximum dose

Most of these side effects might start the moment the supplement is taken, but over time, they lessen

Will I need lab work

4 resM and resG are both formulated with this mechanism in mind.* Parting Thoughts on Constipation From GLP-1 Drugs GLP-1 constipation is uncomfortable, but it's manageable

Since its India launch in March 2025, Mounjaro has accumulated 233 crore in total sales, capturing significant market share in the obesity and diabetes drug segment

Updated February 2026 GLP-1 Drugs and Mental Health: What the Evidence Actually Shows The FDA cleared GLP-1 drugs of psychiatric risk after reviewing 91 trials